For over 30 years, Dr. Dale Bredesen and others around the globe have been pursuing effective treatments for Alzheimer's disease. His ReCODE (Reversing COgnitive DEcline) Protocol is a culmination of these therapies and produces unprecedented results in halting and reversing disease progression. Below are the most pertinent research articles.
Dr. Bredesen's latest published report of 100 patients that were treated by several different physicians, each showing documented improvement in cognition. This report provides further documentation of the success of the protocol (now termed ReCODE) and the overall approach for those with Alzheimer's and its precursors. Link to article here.
Provides details of ten individuals with MCI (mild cognitive impairment) or Alzheimer's disease, who, after individualized treatment addressing suboptimal metabolic parameters, resumed normal cognitive testing results. This improvement was recognized by the patient and people closest to him/her. Link to article here.
The first description of the reversal of cognitive decline in people with early Alzheimer's disease or its precursors, MCI (mild cognitive impairment) and SCI (subjective cognitive impairment), was published in September 2014 by Dr. Bredesen. The multi-factorial and personalized therapeutic approach used was dubbed metabolic enhancement for neurodegeneration (MEND). "The magnitude of the improvement is unprecedented, providing additional objective evidence that this programmatic approach to cognitive decline is highly effective." Link to article here.